Share
Share today's newsletter with a colleague
and get credit if they sign up for SmartBrief.
Referral Count:
0
Story being shared
Experimental pain drug effective at higher dose, study shows
Phase II trial data showed AcelRx Pharmaceuticals' experimental pain drug ARX-04 met the main study goal of reducing acute pain at a dosage of 30 micrograms but not at 20 mcg. The study compared both dosages against a placebo.
Reuters (4/24)
Or we can send an email on your behalf